Molecular marker for anticoagulant protein C pathway (APC-PCi complex)
Hamada, T.; Kamada, H.; Suzuki, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 12): 674-677
2004
ISSN/ISBN: 0047-1852 PMID: 15658421 Document Number: 575629
Document emailed within 1 workday
Related Documents
Toulon, P. 2001: Clinical usefulness of global assays of the anticoagulant pathway of protein C Annales de Biologie Clinique 59(5): 545-550Bin Hanif, T.; Anwar, J.; Idrees, M. 2011: Evaluation of Pro-C global for identification of defects in protein C/S anticoagulant pathway Journal of Ayub Medical College Abbottabad: Jamc 23(1): 89-91
Huber, R.; Römisch, J.; Paques, E.P. 1990: The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes EMBO Journal 9(12): 3867-3874
Koga, S. 2004: A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF) Rinsho Byori. Japanese Journal of Clinical Pathology 52(4): 355-361
Hayashi, T.; Suzuki, K. 1993: Molecular biology of protein C-thrombomodulin pathway. Structure and function, and basic studies on its clinical application Nihon Rinsho. Japanese Journal of Clinical Medicine 51(6): 1610-1619
Comincini, S.; Facoetti, A.; Del Vecchio, I.; Peoc'h, K.; Laplanche, J-Louis.; Magrassi, L.; Ceroni, M.; Ferretti, L.; Nano, R. 2004: Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression Anticancer Research 24(3a): 1507-1517
Close, P.; Creppe, C.; Cornez, I.; Chariot, M.A.; Chariot, A. 2007: Molecular and cellular characterization ion of IKAP protein and the Elongator complex. Implications for familial dysautonomia Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 162(5-6): 315-322
Lu, J.H.; Thiel, S.; Wiedemann, H.; Timpl, R.; Reid, K.B. 1990: Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q Journal of Immunology 144(6): 2287-2294
Pattison, N.S.; McKay, E.J.; Liggins, G.C.; Lubbe, W.F. 1987: Anticardiolipin antibodies: their presence as a marker for lupus anticoagulant in pregnancy New Zealand Medical Journal 100(817): 61-64
Mukherjee, M.; Ranlall, N.; Patel, G.; Rutlin, A.; Jehanli, A.; Kakkar, V.V. 2000: Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 11(3): 285-291
Niculescu, F.; Rus, H.; van Biesen, T.; Shin, M.L. 1997: Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent Journal of Immunology 158(9): 4405-4412
Nishioka, K. 1970: Complement and immune complex. Molecular anatomy and function of C3 molecule on antigen-antibody complex Folia Allergologica 17(4): 427
Millot, F.; Bara, L.; Etienne, J.; Samama, M.; Laruelle, P. 1987: Lipolytic and anticoagulant activities of heparin and one of its low molecular weight derivatives Nouvelle Revue Francaise d'Hematologie 29(6): 397-400
Dahm, M.; Lotz, J.; Hafner, G.; Oelert, H.; Prellwitz, W. 1998: Value of molecular markers for administration of anticoagulant therapy after heart valve replacement Zeitschrift für Kardiologie 87(Suppl 4): 42-45
Romero Barbero, J.L.; Montesinos Fernández, C.; Marcos Herrero, E. 1992: Association of protein S deficiency and lupus anticoagulant Medicina Clinica 99(11): 437
Mitchell, C.A.; Kelemen, S.M.; Salem, H.H. 1988: The anticoagulant properties of a modified form of protein S Thrombosis and Haemostasis 60(2): 298-304
Gschwandtner, M.E.; Eichinger, S.; Hütter, D.; Korninger, L.; Lechner, K.; Panzer, S.; Pabinger, I. 1996: Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 7(3): 325-330
Harenberg, J.; Stehle, G.; Dempfle, C.E.; von Hodenberg, E.; Heene, D.L. 1989: The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects Folia Haematologica 116(6): 967-980
Greten, J.; Kemkes-Matthes, B.; Nawroth, P.P. 1995: Prothrombin complex concentrate contains protein Z and prevents bleeding in a patient with protein Z deficiency Thrombosis and Haemostasis 74(3): 992-993
Brugger, W. 2012: Molecular marker analyses from the SATURN trial Clinical Advances in Hematology and Oncology: H&o 10(1): 33-34